Merck Q3 net declines by 28%
China Daily | Updated: 2009-10-27 08:39
|
The company said it expects the Merck Serono drug division's FY revenue to rise 6 percent, while the consumer health care division's revenue may rise 5 percent. Bloomberg News |
FRANKFURT: German drug and chemical maker Merck KGaA reported yesterday that net income fell 28 percent to 144 million euros ($216 million) in the third quarter as weak demand hurt revenue, but said its chemicals and liquid crystals divisions were recovering.
Photo
